# Xinyu Pharmaceutical Co., Ltd. - Inspection Records

Source: https://www.keypedia.com/companies/xinyu-pharmaceutical-co-ltd/f603cb84-26a5-448f-9d9d-c25547afa6b7

> Inspection records and compliance data for Xinyu Pharmaceutical Co., Ltd. in Suzhou, None. Access full analysis and detailed observations.

---

## Details

- Name: Xinyu Pharmaceutical Co., Ltd.
- FEI Number: 3006895831
- City: Suzhou
- State: None
- Country Name: China
- Address Line 1: 158 Jintai 5th Rd, Economic Development
- Zip Code: None
- Business Operations: API MANUFACTURE

## Related Documents

- [483 - Xinyu Pharmaceutical Co., Ltd. - 2025-06-27](https://www.keypedia.com/records/483/xinyu-pharmaceutical-co-ltd/83f16c3e-5e47-4860-ada0-6d88cb927710) — source: FDA, date: June 27, 2025
- [483 - Xinyu Pharmaceutical Co., Ltd. - 2025-06-27](https://www.keypedia.com/records/483/xinyu-pharmaceutical-co-ltd/93161494-c852-4989-b601-9734af6bdd03) — source: FDA, date: June 27, 2025
- [FDA Inspection 1275189 - Xinyu Pharmaceutical Co., Ltd. - 2025-06-27](https://www.keypedia.com/records/fda_inspections/xinyu-pharmaceutical-co-ltd/c7cd5c5a-46ef-4348-90e8-716d0c4c7ecc) — source: FDA, date: June 27, 2025
- [FDA Inspection 1275189 - Xinyu Pharmaceutical Co., Ltd. - 2025-06-27](https://www.keypedia.com/records/fda_inspections/xinyu-pharmaceutical-co-ltd/283eb1c8-6f30-4140-bf37-2d5e2aa74469) — source: FDA, date: June 27, 2025
- [FDA Inspection 1275189 - Xinyu Pharmaceutical Co., Ltd. - 2025-06-27](https://www.keypedia.com/records/fda_inspections/xinyu-pharmaceutical-co-ltd/f9f74026-f76d-4312-8967-e3780bbfd944) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 27, 2025
- [FDA Inspection 1275189 - Xinyu Pharmaceutical Co., Ltd. - 2025-06-27](https://www.keypedia.com/records/fda_inspections/xinyu-pharmaceutical-co-ltd/69756aae-3bd1-4e07-936a-f6468a481cab) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 27, 2025
- [FDA Inspection 1086507 - Xinyu Pharmaceutical Co., Ltd. - 2019-03-15](https://www.keypedia.com/records/fda_inspections/xinyu-pharmaceutical-co-ltd/ca0044cd-6287-415c-b20a-1e8d037f3575) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 15, 2019
- [FDA Inspection 1086507 - Xinyu Pharmaceutical Co., Ltd. - 2019-03-15](https://www.keypedia.com/records/fda_inspections/xinyu-pharmaceutical-co-ltd/de9b2323-43dd-4899-96df-8d8c3fc24a09) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 15, 2019
- [483 - Xinyu Pharmaceutical Co., Ltd. - 2019-03-11](https://www.keypedia.com/records/483/xinyu-pharmaceutical-co-ltd/0e6760db-5d5a-4439-85e6-9adc6f471c6a) — source: FDA, date: March 11, 2019
- [FDA Inspection 985067 - Xinyu Pharmaceutical Co., Ltd. - 2016-09-14](https://www.keypedia.com/records/fda_inspections/xinyu-pharmaceutical-co-ltd/e26ee834-c3a5-4f3a-9489-d239632f4909) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 14, 2016
- [FDA Inspection 985067 - Xinyu Pharmaceutical Co., Ltd. - 2016-09-14](https://www.keypedia.com/records/fda_inspections/xinyu-pharmaceutical-co-ltd/3452a7ca-f1d2-4042-81d2-f9159753e1bb) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 14, 2016
- [FDA Inspection 824355 - Xinyu Pharmaceutical Co., Ltd. - 2013-03-14](https://www.keypedia.com/records/fda_inspections/xinyu-pharmaceutical-co-ltd/0a93f2a8-b8be-4c8a-8511-80fbfbaf2275) — classification: No Action Indicated (NAI), source: FDA, date: March 14, 2013
- [FDA Inspection 656301 - Xinyu Pharmaceutical Co., Ltd. - 2010-03-12](https://www.keypedia.com/records/fda_inspections/xinyu-pharmaceutical-co-ltd/671e344e-ebd9-4b99-900f-959912ae2506) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 12, 2010

## Related Companies

- [Veranova LP](https://www.keypedia.com/companies/veranova-lp/22f7ea09-da55-4ee1-aa40-fce66fa3ef61)
- [ChemPacific Corporation](https://www.keypedia.com/companies/chempacific-corporation/193b1f68-27d2-4a77-af09-995fc39a7c20)
- [AURORIUM LLC](https://www.keypedia.com/companies/aurorium-llc/1381f644-a64d-49a5-a1bb-b57426080e7d)
- [Jiangsu Baozong & Baoda Pharmachem Co., Ltd.](https://www.keypedia.com/companies/jiangsu-baozong-baoda-pharmachem-co-ltd/b353c82d-34a4-40db-8541-3540be220c7d)
- [MicroBiopharm Japan Co., Ltd.](https://www.keypedia.com/companies/microbiopharm-japan-co-ltd/30cd7895-86c9-46ed-bee9-e7131c700977)
- [Hikal Limited](https://www.keypedia.com/companies/hikal-limited/cb3e9445-04eb-4d52-af78-793b43f9d61f)
- [ALI Pharmaceutical Manufacturing LLC](https://www.keypedia.com/companies/ali-pharmaceutical-manufacturing-llc/d3d0fcce-e7cb-4f71-8042-2726fd64e8a8)
- [J.M Huber Micropowders, Inc](https://www.keypedia.com/companies/jm-huber-micropowders-inc/29e05493-3c2b-4d4b-ac8d-da0ba1cefba8)
- [VUAB Pharma a.s.](https://www.keypedia.com/companies/vuab-pharma-as/6caae203-57d0-4a6f-b2b8-340c40ec5135)
- [Shouguang Fukang Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/shouguang-fukang-pharmaceutical-co-ltd/c6836369-cde1-4980-97c8-314af897d7e1)

## Related Officers

- [Marijo B. Kambere](https://www.keypedia.com/people/marijo-b-kambere/54e010f0-0d56-4b20-b5e2-112e372de58b)
- [Investigator](https://www.keypedia.com/people/marvin-d-jones/3101a8da-f5c1-4e0c-b4b1-b09be181be36)